CBLSX
Price
$10.46
Change
-$0.04 (-0.38%)
Updated
Jan 22 closing price
Net Assets
165.23M
RMFEX
Price
$56.68
Change
-$0.04 (-0.07%)
Updated
Jan 22 closing price
Net Assets
104.52B
Ad is loading...

CBLSX vs RMFEX

Header iconCBLSX vs RMFEX Comparison
Open Charts CBLSX vs RMFEXBanner chart's image
Allspring Large Cap Value Inst
Price$10.46
Change-$0.04 (-0.38%)
VolumeN/A
Net Assets165.23M
American Funds American Mutual R4
Price$56.68
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets104.52B
CBLSX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBLSX vs. RMFEX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBLSX is a Buy and RMFEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 105B vs. CBLSX (165M). RMFEX pays higher dividends than CBLSX: RMFEX (1.95) vs CBLSX (1.44). CBLSX was incepted earlier than RMFEX: CBLSX (21 years) vs RMFEX (23 years). CBLSX is a more actively managed with annual turnover of: 29.00 vs. RMFEX (25.00). RMFEX has a lower initial minimum investment than CBLSX: RMFEX (250) vs CBLSX (1000000). RMFEX annual gain was more profitable for investors over the last year : 12.66 vs. CBLSX (-10.11). RMFEX return over 5 years is better than : 42.55 vs. CBLSX (-24.32).
CBLSXRMFEXCBLSX / RMFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years23 years-
Gain YTD3.7703.205118%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets165M105B0%
Annual Yield % from dividends1.441.9574%
Returns for 1 year-10.1112.66-80%
Returns for 3 years-29.7017.39-171%
Returns for 5 years-24.3242.55-57%
Returns for 10 years-9.0771.65-13%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRM0.470.01
+2.59%
SRM Entertainment
IKT2.80-0.01
-0.36%
Inhibikase Therapeutics
GEF61.25-0.93
-1.50%
Greif
VTR58.36-1.93
-3.20%
Ventas
UTL53.05-2.03
-3.69%
Unitil Corp